{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:11Z","timestamp":1794045791436,"version":"4.8.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Patients with Ehlers\u2013Danlos syndrome (EDS) have many associated symptoms of unclear cause, most recently suggested to be due to small fiber neuropathy (SFN). Small fiber neuropathies are sorely underestimated and with minimal treatment options. We report 2 cases of patients with EDS with presumed immune-mediated SFN, successfully treated with IV immunoglobulins. There is a stark need for further investigational studies into immunosuppressant treatments for immune-mediated SFN as well as the link between EDS and immune-mediated SFN.<\/jats:p>","DOI":"10.1097\/cnd.0000000000000341","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T21:15:18Z","timestamp":1614374118000},"page":"160-163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Autoimmune Small Fiber Neuropathy Associated With Ehlers\u2013Danlos Syndrome Treated With Intravenous Immunoglobulins"],"prefix":"10.1097","volume":"22","author":[{"given":"Melissa K.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10072-019-03871-x","article-title":"Small-fiber neuropathy definition, diagnosis, and treatment","volume":"40","author":"Basantsova","year":"2019","journal-title":"Neurol Sci."},{"key":"R2-20250507","first-page":"1411","article-title":"Sensory polyneuropathies","volume":"23","author":"Gwathmey","year":"2017","journal-title":"CONTINUUM."},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11910-019-1020-1","article-title":"Current diagnosis and treatment of painful small fiber neuropathy","volume":"19","author":"Farhad","year":"2019","journal-title":"Curr Neurol Neurosci Rep."},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1212\/WNL.0000000000002847","article-title":"Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes","volume":"87","author":"Cazzato","year":"2016","journal-title":"Neurology."},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000498858","article-title":"How we treat autoimmune small fiber polyneuropathy with immunoglobulin therapy","volume":"80","author":"Schofield","year":"2018","journal-title":"Eur Neurol."},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jnnp.52.4.539-a","article-title":"Autonomic neuropathy in systemic lupus erythematosus","volume":"52","author":"Arruda","year":"1989","journal-title":"J Neurol Neurosurg Psychiat."},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13063-016-1450-x","article-title":"Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial","volume":"17","author":"de Greef","year":"2016","journal-title":"Trials."},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.26748","article-title":"Cryptogenic small-fiber neuropathies: serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3","volume":"61","author":"Levine","year":"2020","journal-title":"Muscle Nerve."},{"key":"R9-20250507","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mus.10301","article-title":"Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide","volume":"27","author":"Pestronk","year":"2003","journal-title":"Muscle Nerve."},{"key":"R10-20250507","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mus.23256","article-title":"Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS","volume":"45","author":"Pestronk","year":"2012","journal-title":"Muscle Nerve."},{"key":"R11-20250507","first-page":"95","article-title":"The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis","volume":"105","author":"Hoitsma","year":"2011","journal-title":"Repir Med."}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:04:25Z","timestamp":1746651865000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000341","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}